In the largest study to date of the Arthritis Foundation’s Tai Chi program, participants showed improvement in pain, fatigue, stiffness and sense of well-being. Their ability to reach while maintaining balance also improved, said Leigh Callahan, PhD, the study’s lead author, associate professor in the University of North Carolina at Chapel Hill School of Medicine [...]
BioTrends Research Group, Inc. recently announced the release of their latest annual report regarding the management and treatment of multiple sclerosis (MS) in the US, which is compiled using data obtained directly from MS patients who are currently receiving treatment in the form of disease modifying agents (DMAs). The comprehensive report, titled ChartTrends: Multiple Sclerosis, [...]
Stater Bros. Supermarkets recently announced its decision to distribute several diabetes medications free of charge to diabetes patients throughout the month of November, which is the National Diabetes Awareness Month. The following diabetes medications will be available from all Stater Bros. Super Rx Pharmacy locations, to all diabetes patients, as long as they have a [...]
The results of a recent study, conducted by researchers at the Dana-Farber Cancer Institute, highlighted the importance of using treatment strategies that are personalized to individual patients in the treatment of genetically defined cancers. The researchers reported that they had managed to achieve significant results in terms treating a rare and aggressive form of soft-tissue [...]
Doctors at the University of Texas MD Anderson Cancer Center have recently begun to treat lung cancer patients using an advanced form of radiation treatment known as pencil beam scanning proton therapy, which enables the delivery of radiation treatment to a tumor with incredible precision, and thereby minimizes the damage to the healthy tissue surrounding [...]
Ceregene, Inc., a biotechnology company based in San Diego, recently announced the commencement of a Phase 2b study that aims to establish the efficacy of CERE-120 in the treatment of Parkinson’s disease. CERE-120 consists of an adeno-associated virus (AAV) vector, which carries the gene for a naturally occurring protein known as neurturin, which is capable [...]
Naltrexone is a drug that was initially developed in order to assist drug addicts to kick their drug habit, but was later found to be of significant benefit to sufferers of Multiple Sclerosis (MS) when prescribed in low doses. This has resulted in Low Dose Naltrexone (LDN) becoming an increasingly popular choice for the treatment [...]
Pradaxa (dabigatran etexilate), which is an anticoagulant drug manufactured by Boehringer Ingelheim Pharmaceuticals Inc., was recently granted approval by the U.S. Food and Drug Administration (FDA) to be used in the treatment of patients diagnosed with atrial fibrillation, the most common form of cardiac arrhythmia. Atrial fibrillation occurs as a result of fast, uncoordinated contractions [...]
The U.S. Food and Drug Administration (FDA) recently granted approval for the use of Botox (onabotulinumtoxinA) in the treatment of chronic migraine. Russell Katz M.D., the Director of the Division of Neurology Products in the FDA’s Center for Drug Evaluation and Research, issued the following statement regarding the new approval: “Chronic migraine is one of [...]
Researchers at the University of Granada recently announced that they had successfully used a new technique known as FDG positron emission tomography scanning to diagnose gall bladder cancer, achieving results that were understood to be significantly more accurate than current diagnostic methods. Gall bladder cancer is an extremely deadly form of cancer, which makes an [...]
